Poseida News Center

Read media coverage on Poseida, find resources for the working press, and get insights from our executive leadership team on the next wave of cell and gene therapies.

Featured Content

Developing Nonviral Gene Therapy for Hemophilia A

Developing Nonviral Gene Therapy for Hemophilia A

CGTLive | January 9, 2023

hemophilia A gene therapy

Takeda’s Poseida Partnership Starts to Pay Off with Promising Hemophilia A Gene Therapy Data

Fierce Biotech | December 14, 2022

The Top Line

The Top Line

Fierce Biotech | November 11, 2022

Executive Perspectives

Thankful for Dreams, Plans and Reality

Thankful for Dreams, Plans and Reality

By Mark Gergen, Chief Executive Officer
LinkedIn | Nov 17, 2022

Executive Perspectives - Eric Ostertag

Poseida Therapeutics: Creating the Next Wave of Cell & Gene Therapies With the Capacity to Cure

By Eric Ostertag, M.D., Ph.D., Executive Chairman
Drug Development & Delivery | September 1, 2021

Executive Perspectives - Kerry Ingalls

Keys to the Successful Preclinical-Clinical Translation of Next-Gen CAR-T Cell Therapy

By Devon Shedlock, Ph.D., Chief Scientific Officer, Cell Therapies
Cell & Gene Therapy Insights | February 8, 2022 (registration required)

Media Library

Usage rights & restrictions: These media assets are free for editorial broadcast, print, online and radio use. They are restricted for other purposes.
If you are a member of the working press and need a resource that is not available on this website, please e-mail your request to sthailing@poseida.com and we will make every effort to respond as soon as possible.

Corporate Images

Headshots

Logos

MENU